> Program > Scientific Program
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:52 | An integrative approach to cancer based on precision medicine |
| 08:52-09:14 | Biomarkers in the diagnosis of gastric cancer | |
| 09:14-09:36 | Proteomics for PIVKA-II in HCC surveillance | |
| 09:36-09:58 | Esophageal impedance test: A new diagnostic approach for GERD and functional esophageal disorder | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:37 | Tailored therapy for refractory Helicobacter pylori infection |
| 10:37-10:59 | Personalized therapeutic approach to inflammatory bowel disease | |
| 10:59-11:21 | State of the art for liquid biomarkers in pancreatic cancer: An important consideration in the era of precision oncology | |
| 11:21-11:43 | The emerging role of liquid biopsy in digestive cancer | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:47 | Big data research in IBD: From real world data to real world evidence |
| 12:47-13:09 | Deep dive into bioinformatics in gastrointestinal cancer | |
| 13:09-13:31 | Development of therapeutic decision model in hepatology using artificial intelligence | |
| 13:31-13:53 | Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:32 | Early detection and stratification of gastric cancer through stem cell marker and miRNA |
| 14:32-14:54 | Overcoming peritoneal metastasis of colon cancer with STING-based immunotherapy | |
| 14:54-15:16 | Anti-tumor therapy of HCC using CAR T Cells derived from iPS cell | |
| 15:16-15:38 | Nano-bio system for the capture of pancreatic cancer cell secreted exosomes | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:52 | The role of endoscopy in achalasia |
| 08:52-09:14 | The role of endoscopy and biopsy in chronic diarrhea with IBS-D | |
| 09:14-09:36 | The role of endoscopy in intestinal pseudo-obstruction, adult Hirschsprung's disease | |
| 09:36-09:58 | Anti-reflux endoscopic surgery for Gastroesophageal Reflux Disease | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:37 | The microbiota of early life and developmental immunology |
| 10:37-10:59 | The effect of immunologic factors in IBS | |
| 10:59-11:21 | Microbial modulation of inflammation in IBD | |
| 11:21-11:43 | Immune response and gut microbiome in colorectal cancer | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:47 | Classification criteria for IgG4-related disease |
| 12:47-13:09 | Second line management of autoimmune hepatitis | |
| 13:09-13:31 | Novel immune therapy in IBD | |
| 13:31-13:53 | Novel therapy in primary sclerosing cholangitis | |
| Date / Time | 299, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:32 | Gastric cancer |
| 14:32-14:54 | Colon cancer | |
| 14:54-15:16 | Hepatocellular carcinoma | |
| 15:16-15:38 | Pancreatic cancer | |